CN1287554A - 新的旋光的氨基戊烷衍生物 - Google Patents
新的旋光的氨基戊烷衍生物 Download PDFInfo
- Publication number
- CN1287554A CN1287554A CN99801857A CN99801857A CN1287554A CN 1287554 A CN1287554 A CN 1287554A CN 99801857 A CN99801857 A CN 99801857A CN 99801857 A CN99801857 A CN 99801857A CN 1287554 A CN1287554 A CN 1287554A
- Authority
- CN
- China
- Prior art keywords
- compound
- composition
- compounds
- effect
- isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Abstract
Description
100微摩尔/升 | 10微摩尔/升 | |
本发明化合物 | 126.42±8.04* | 104.94±4.96 |
(+)-异构体化合物 | 116.72±6.91 | 124.41±12.54 |
外消旋化合物 | 112.10±36.98 | 90.28±2.85 |
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34775698A JP4499208B2 (ja) | 1998-10-29 | 1998-10-29 | 新規な光学活性アミノペンタン誘導体 |
JP347756/1998 | 1998-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1287554A true CN1287554A (zh) | 2001-03-14 |
CN1131858C CN1131858C (zh) | 2003-12-24 |
Family
ID=18392375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN998018570A Expired - Fee Related CN1131858C (zh) | 1998-10-29 | 1999-10-15 | 旋光的氨基戊烷衍生物 |
Country Status (17)
Country | Link |
---|---|
US (1) | US6391914B1 (zh) |
EP (1) | EP1052259B1 (zh) |
JP (1) | JP4499208B2 (zh) |
KR (1) | KR100603112B1 (zh) |
CN (1) | CN1131858C (zh) |
AT (1) | ATE360009T1 (zh) |
AU (1) | AU762995B2 (zh) |
CA (1) | CA2317036C (zh) |
DE (1) | DE69935849T2 (zh) |
DK (1) | DK1052259T3 (zh) |
ES (1) | ES2285861T3 (zh) |
HK (1) | HK1032585A1 (zh) |
HU (1) | HU228299B1 (zh) |
IL (1) | IL136977A0 (zh) |
PT (1) | PT1052259E (zh) |
SI (1) | SI20209A (zh) |
WO (1) | WO2000026204A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101065123B (zh) * | 2004-11-25 | 2012-02-15 | 国立大学法人九州大学 | 药物依赖症治疗剂 |
CN106163514A (zh) * | 2013-12-25 | 2016-11-23 | 藤本株式会社 | 注意缺陷和多动性障碍的预防及治疗剂 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4691230B2 (ja) * | 2000-04-11 | 2011-06-01 | 株式会社フジモト・コーポレーション | 光学活性1−(ベンゾフラン−2−イル)−2−プロピルアミノペンタンの製造方法 |
JP4888751B2 (ja) * | 2001-09-14 | 2012-02-29 | 株式会社フジモト・コーポレーション | トリフルオロプロピルアミノペンタン誘導体及びその製造方法 |
JP4953040B2 (ja) * | 2001-09-19 | 2012-06-13 | 株式会社フジモト・コーポレーション | アポトーシス抑制剤 |
EP2158908B1 (en) * | 2007-06-21 | 2013-04-24 | Fujimoto Co., Ltd. | Composition for transdermal administration |
CA2968793C (en) | 2014-12-05 | 2022-02-08 | Semmelweis University | Compounds for use in the prevention or treatment of cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
HUT63579A (en) * | 1991-12-20 | 1993-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
JPH0859578A (ja) * | 1994-06-17 | 1996-03-05 | Taisho Pharmaceut Co Ltd | 置換フェニルアルキルアミン誘導体 |
WO1999007667A1 (fr) * | 1997-08-07 | 1999-02-18 | Fujimoto Brothers Co., Ltd. | Nouveaux derives d'ethylamine |
-
1998
- 1998-10-29 JP JP34775698A patent/JP4499208B2/ja not_active Expired - Fee Related
-
1999
- 1999-10-15 ES ES99947940T patent/ES2285861T3/es not_active Expired - Lifetime
- 1999-10-15 SI SI9920013A patent/SI20209A/sl not_active IP Right Cessation
- 1999-10-15 DK DK99947940T patent/DK1052259T3/da active
- 1999-10-15 CN CN998018570A patent/CN1131858C/zh not_active Expired - Fee Related
- 1999-10-15 EP EP99947940A patent/EP1052259B1/en not_active Expired - Lifetime
- 1999-10-15 IL IL13697799A patent/IL136977A0/xx not_active IP Right Cessation
- 1999-10-15 PT PT99947940T patent/PT1052259E/pt unknown
- 1999-10-15 US US09/581,747 patent/US6391914B1/en not_active Expired - Lifetime
- 1999-10-15 DE DE69935849T patent/DE69935849T2/de not_active Expired - Lifetime
- 1999-10-15 KR KR1020007007280A patent/KR100603112B1/ko not_active IP Right Cessation
- 1999-10-15 WO PCT/JP1999/005729 patent/WO2000026204A1/ja active IP Right Grant
- 1999-10-15 AU AU61241/99A patent/AU762995B2/en not_active Ceased
- 1999-10-15 AT AT99947940T patent/ATE360009T1/de active
- 1999-10-15 HU HU0004667A patent/HU228299B1/hu not_active IP Right Cessation
- 1999-10-15 CA CA002317036A patent/CA2317036C/en not_active Expired - Fee Related
-
2001
- 2001-05-08 HK HK01103235A patent/HK1032585A1/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101065123B (zh) * | 2004-11-25 | 2012-02-15 | 国立大学法人九州大学 | 药物依赖症治疗剂 |
CN106163514A (zh) * | 2013-12-25 | 2016-11-23 | 藤本株式会社 | 注意缺陷和多动性障碍的预防及治疗剂 |
Also Published As
Publication number | Publication date |
---|---|
WO2000026204A1 (fr) | 2000-05-11 |
JP4499208B2 (ja) | 2010-07-07 |
DK1052259T3 (da) | 2007-08-06 |
AU6124199A (en) | 2000-05-22 |
DE69935849T2 (de) | 2008-01-10 |
US6391914B1 (en) | 2002-05-21 |
HUP0004667A3 (en) | 2001-10-29 |
SI20209A (sl) | 2000-10-31 |
EP1052259A1 (en) | 2000-11-15 |
IL136977A0 (en) | 2001-06-14 |
JP2000136187A (ja) | 2000-05-16 |
EP1052259A4 (en) | 2001-10-24 |
DE69935849D1 (de) | 2007-05-31 |
KR20010033756A (ko) | 2001-04-25 |
CA2317036A1 (en) | 2000-05-11 |
PT1052259E (pt) | 2007-07-20 |
EP1052259B1 (en) | 2007-04-18 |
ES2285861T3 (es) | 2007-11-16 |
AU762995B2 (en) | 2003-07-10 |
KR100603112B1 (ko) | 2006-07-20 |
HUP0004667A2 (hu) | 2001-04-28 |
HK1032585A1 (en) | 2001-07-27 |
HU228299B1 (en) | 2013-03-28 |
ATE360009T1 (de) | 2007-05-15 |
CA2317036C (en) | 2009-05-19 |
CN1131858C (zh) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1046515C (zh) | 二氮杂双环神经激肽拮抗剂 | |
Ma et al. | Sugar‐based synthesis of Tamiflu and its inhibitory effects on cell secretion | |
CN101050199A (zh) | (-)-1-(3,4-二氯苯基)-3-氮杂二环[3.1.0]己烷及其组合物和作为多巴胺再摄取抑制剂的应用 | |
CN1131858C (zh) | 旋光的氨基戊烷衍生物 | |
CN1196681C (zh) | (+)诺西沙必利用于制备5-ht3和5ht4 介导的疾病的药物中的用途 | |
Popik et al. | Pharmacological profile of the “triple” monoamine neurotransmitter uptake inhibitor, DOV 102,677 | |
EP2819516A1 (en) | Use of (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo{3.1.0}hexane in the treatment of conditions affected by monoamine neurotransmitters | |
van Waarde et al. | Imaging beta-adrenoceptors in the human brain with (S)-l′-[18F] fluorocarazolol | |
US20200215089A1 (en) | Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity | |
CN1810252A (zh) | 松果菊苷的制药新用途 | |
Andrews et al. | Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos | |
US20140037544A1 (en) | Labeled iodinated tropane formulation | |
Schmaljohann et al. | In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F] F-A85380 in Parkinson's disease | |
CN1596263A (zh) | 芳基-稠合的氮杂多环化合物 | |
CN1833655A (zh) | 三磷酸胞苷二钠输液及其制备工艺 | |
Reynolds | Post-mortem neurochemistry of schizophrenia1 | |
US6552087B1 (en) | Therapeutic agent comprising (+)-sibutramine | |
CN101868233A (zh) | 与血清素双重作用化合物有关的组合疗法 | |
CN1609086A (zh) | Mptp亲和标记物 | |
Agurell | Biogenic amines and depression (introduction to symposium) | |
CN101041689A (zh) | 环孢菌素c和d的衍生物及其药物组合物 | |
CN1989966A (zh) | 含利福平和异烟肼的药物组合物 | |
CN1590373A (zh) | 1-(4-羟苯基)-2-(4-羟基-4-苯基哌啶-1-基)-1-丙醇的甲磺酸盐三水合物的制备方法 | |
CN1845730A (zh) | 5-羟色胺再摄取抑制剂与克塞平的组合 | |
CN1153777C (zh) | 制备活性炭-gm1络合物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FUJIMOTO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TOMOYISHI MOTOPULAZEZ CORP. Effective date: 20101028 Owner name: FUJIMOTO CO., LTD. Free format text: FORMER OWNER: FUJIMOTO PHARMACEUTICAL CO., LTD. Effective date: 20101028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20101028 Address after: Japan Osaka Patentee after: FUJIMOTO Co.,Ltd. Address before: Japan Osaka Patentee before: FUJIMOTO PHARMACEUTICAL Corp. Effective date of registration: 20101028 Address after: Japan Osaka Patentee after: FUJIMOTO PHARMACEUTICAL Corp. Address before: Japan Osaka Patentee before: Fujimoto Brothers Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20031224 Termination date: 20141015 |
|
EXPY | Termination of patent right or utility model |